Enzo BiochemENZB
13F holders, Q2 2025 (June 30)7holders −34
2new positions
37sold out
$0.68avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Enzo Biochem Inc. (ENZB) in their 13F filings, down 34 from Q1 2025. 2 opened new positions and 37 sold out. The largest holders were Oddo BHF Asset Management Sas ($1.7M), RBF Capital, LLC ($102K) and Squarepoint Ops LLC ($95K).
- Company
- Enzo Biochem Inc.
- CUSIP
- 294100102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.8M |
| Exits | 37 | $4.8M |
All 13F filers, Q1 2025 → Q2 2025: 2,625,645 shares bought and 13,093,390 shares sold, net −10,467,745 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Oddo BHF Asset Management Sas | 0.07% | New | 2,575,000 | $1.7M |
| RBF Capital, LLC | 0.01% | Reduce -40.1% | 150,000 | $102K |
| Squarepoint Ops LLC | 0.00% | Add +10.4% | 140,637 | $95K |
| XTX Topco Ltd | 0.00% | Add +111.8% | 44,880 | $30K |
| Kempner Capital Management Inc. | 0.01% | No change | 25,475 | $17K |
| Ground Swell Capital, LLC | 0.02% | New | 13,761 | $9K |
| Simplex Trading, LLC | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is ENZB's weight in each manager's 13F, not the share of Enzo Biochem Inc. the manager owns.